Full Length Research Paper
References
|
Achkar JM, Fries BC (2010). Candida infections of the genitourinary tract. Clinical Microbiology Reviews 23:253-273. |
|
|
Amouri I, Abbes S, Sellami H, Makni F, Sellami A, Ayadi A (2010). La candidose vulvovaginale: revue. Journal de Mycologie Médicale 20:108-115. |
|
|
Anh DN, Hung DN, Tien TV, Dinh VN, Son VT, Luong NV, Van NT, Quynh NT, Van Tuan N, Tuan LQ, Bac ND (2021). Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam. BMC Infectious Diseases 21:523. |
|
|
Barajas JF, Wehrs M, To M, Cruickshanks L, Urban R, McKee A, Gladden J, Goh EB, Brown ME, Pierotti D, Carothers JM (2019). Isolation and characterization of bacterial cellulase producers for biomass deconstruction: A microbiology laboratory course. Journal of Microbiology and Biology Education 20(2):50. |
|
|
Berman J, Sudbery PE (2002). Candida albicans: a molecular revolution built on lessons from budding yeast. Nature Reviews Genetics 3:918-930. |
|
|
Bitew A, Abebaw Y (2018). Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC Womens Health 18:94. |
|
|
Boye CS, Dubrous P, Mahou C, Diallo TA, Koumondji LK, Mangou K, Dieng A, Diouf MD, Diop A, Seck A, Diongue K (2022). Vulvovaginal candidiasis at Institute Pasteur of Dakar, Senegal: Prevalence and associated risk factors. Journal of Advances in Microbiology 113-119. |
|
|
Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R (2018) Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infectious Diseases 18:e339-e347. |
|
|
Felix TC, de Brito Röder DVD, Dos Santos Pedroso R (2019). Alternative and complementary therapies for vulvovaginal candidiasis. Folia Microbiologica (Praha) 64:133-141. |
|
|
Ghaddar N, Anastasiadis E, Halimeh R, Ghaddar A, Dhar R, AlFouzan W, Yusef H, El Chaar M (2020). Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon. BMC Infectious Diseases 20(1):1-9. |
|
|
Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S (2016). Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Critical Reviews in Microbiology 42:905-927. |
|
|
Kpongbo EA, Djohan V, Vanga-Bosson HA, Kassi KF, Konatà A, Kiki-Barro CP, Yavo W (2018). Susceptibility of Candida species isolated from recurrent vulvovaginal candidiasis to antifungal agents among women at Institut Pasteur of Cte dIvoire. Journal of Yeast and Fungal Research 9:21-26. |
|
|
Nejat ZA, Farahyar S, Falahati M, Khozani MA, Hosseini AF, Faiazy A, Ekhtiari M, Hashemi-Hafshenjani S (2018). Molecular identification and antifungal susceptibility pattern of non-albicans candida species isolated from Vulvovaginal candidiasis. Iran Biomedical Journal 22:33-41. |
|
|
Nicholls S, MacCallum DM, Kaffarnik FA, Selway L, Peck SC, Brown AJ (2011). Activation of the heat shock transcription factor Hsf1 is essential for the full virulence of the fungal pathogen Candida albicans. Fungal Genetics and Biology 48:297-305. |
|
|
Rathod SD, Klausner JD, Krupp K, Reingold AL, Madhivanan P (2012). Epidemiologic features of Vulvovaginal Candidiasis among reproductive-age women in India. Infectious Diseases in Obstetrics and Gynecology 2012:859071. |
|
|
Rezaei-Matehkolaei A, Shafiei S, Zarei-Mahmoudabadi A (2016). Isolation, molecular identification, and antifungal susceptibility profiles of vaginal isolates of Candida species. Iranian Journal of Microbiology 8:410-417. |
|
|
Seck MC, Faye B, Ndiaye M, Sow A, Lô G, Biadiane A (2015). Prevalence of Trichomonas vaginalis and Candida albicans in women at the laboratory of the military hospital of Ouakam, Dakar, Senegal. Médecine d'Afrique Noire 6201(2015):31-37. |
|
|
Sharifynia S, Falahati M, Akhlaghi L, Foroumadi A, Fateh R (2017). Molecular identification and antifungal susceptibility profile of Candida species isolated from patients with vulvovaginitis in Tehran. Journal of Research in Medical Sciences 22:132. |
|
|
Shi Y, Zhu Y, Fan S, Liu X, Liang Y, Shan Y (2020). Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis. BMC Infectious Diseases 20:287. |
|
|
Sobel JD (2007). Vulvovaginal candidosis. Lancet 369(9577):1961-1971. |
|
|
Sobel JD (2016). Recurrent vulvovaginal candidiasis. American Journal of Obstetrics and Gynecology 214(1):15-21. |
|
|
Sylla K (2018). Vulvovaginal candidiasis in the laboratory of parasitology-mycology at Fann university hospital, Dakar (Senegal). Revue Africaine et Malgache de Recherche Scientifique/Sciences de la Santé 5(2). |
|
|
Waikhom SD, Afeke I, Kwawu GS, Mbroh HK, Osei GY, Louis B, Deku JG, Kasu ES, Mensah P, Agede CY, Dodoo C (2020). Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates. BMC Pregnancy Childbirth 20:266. |
|
|
Yadav K, Prakash S (2016). Prevalence of vulvovaginal candidiasis in pregnancy. Global Journal of Medicine and Medical Sciences 4(1):108-116. |
|
|
Yano J, Sobel JD, Nyirjesy P, Sobel R, Williams VL, Yu Q, Noverr MC, Fidel PL (2019). Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Women's Health 19:1-9. |
|
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
